TP53 and endometrial cancer: In recent years, according to the risk of recurrence and progression-free survival, endometrial cancer has been reclassified and divided into the following four categories: DNA polymerase epsilon, microsatellite instability-high/defect mismatch repair (MSI-H/dMMR), TP53-wild-type, and TP53-mutant (12, 13).